학술논문

ALPN-303, an Enhanced, Potent Dual BAFF/APRIL Antagonist Engineered by Directed Evolution for the Treatment of Systemic Lupus Erythematosus (SLE) and Other B Cell-Related Diseases
Document Type
Journal
Source
ARTHRITIS & RHEUMATOLOGY; SEP 2021, 73 p3001-p3004, 4p. Supplement: 9
Subject
Language
English
ISSN
23265205